Guidelines - Europa
V. Reporting periods _____ 5 VI. Transitional arrangements (Article 61 of the AIFMD) _____ 5 ... 17. Tables 8, 9 and 10 in Annex IV set out all the different possible changes in reporting frequency and provide clarification on the scope of the information to be provided. These procedures are based on
Download Guidelines - Europa
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Public consultation on the governance of the Monitoring ...
www.esma.europa.euThe consultation paper rightly refers to International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB) which is overseen by the Trustees of the IFRS Foundation and a Monitoring Board composed of public authorities.
Questions and Answers - ESMA
www.esma.europa.eu16 December 2016 | ESMA/2016/1669 Questions and Answers ... legislation or ESMA guidelines. 4. The European Commission has already published its own Q&A on AIFMD 6. II. Purpose ... part of a department) – can exert material influence on the AIFM’s risk profile or on an AIF it
Guidelines, Question, 2016, Part, Answers, Questions and answers
Guidelines - ESMA
www.esma.europa.eu10 October 2016 | ESMA/2016/1452 Corrected on 07/08/2017 Guidelines Transaction reporting, order record keeping and clock synchronisation under MiFID II
Practical Guide - ESMA
www.esma.europa.euPractical Guide is intended as an aide to market participants and may be particularly helpful to shareholders with notification obligations under national law in …
Questions and Answers - ESMA
www.esma.europa.euApr 08, 2019 · 4 42. Rights issue: communication by a custodian to its clients in one member state about pre-emption rights in relation to a public offer of new shares taking place in another
Guidelines
www.esma.europa.eu5 application of Article 25(2) of MiFID II and of Articles 54 and 55 of the MiFID II Delegated Regulation. 10. ESMA expects these guidelines to promote greater convergence in the interpretation of,
Questions and Answers
www.esma.europa.euRegulation (EU) No 648/2012 of the European Parliament and of the Council of 4 July 2012 on OTC ... European Commission adopted without modifications the regulatory technical standards developed by ... Directive 2004/39/EC of the European Parliament and the Council
European commission, European, Commission, Regulations, 2004, No 648
Final Report
www.esma.europa.euproviders for business Regulation. 2 Date: 10 November 2021 . 3 Date: 10 November 2021 Table of Contents ... CA National competent authority or authorities designated by a Member State ... PRIIPS Regulation (EU) No 1286/2014 of the European Parliament and of the Council of 26 November 2014 on key information documents for ...
Guidelines on Liquidity Stress Testing in UCITS and AIFs
www.esma.europa.euThese Guidelines relate to liquidity stress testing in UCITS and AIFs. 3. In particular, in respect of managers they apply primarily in relation to Article 16(1) of the AIFMD, Articles 47 and 48 of the AIFMD Level 2 Regulation, Article 51 of the UCITS
Guidelines, Testing, Stress, Liquidity, Guidelines on liquidity stress testing
BRIEFING Legal Entity Identifier (LEI) - Europa
www.esma.europa.euLegal Entity Identifier (LEI) The Legal Entity Identifier (LEI) is a 20-digit, alpha-numeric code that enables clear and unique identification of legal entities participating in financial transactions. 1 LEIs, like other identifiers, are needed by firms to fulfil their reporting obligations under financial regulations and directives.
Related documents
Annex 1 : Manufacture of Sterile Products 2 Document map
ec.europa.eu1 Annex 1 : Manufacture of Sterile Products 2 3 Document map Section Number General overview 1. Scope Includes additional areas (other than sterile products) where the ... v.148 The risk management outcome should be reviewed regularly as part of on-going quality 149 management, during change control and during the periodic product quality review.
2021 - European Commission
ec.europa.euthis Annex and under reference numbers 1309, 1311, and 1312 in Annex II Hair dye substance in oxidative hair dye products (a) General use (b) Professional use For (a) and (b): After mixing under oxidative conditions the maximum concentration applied to hair must not exceed 3 % calculated as free base (1 ) These substances may be used singly or in
Report of the Conference of the Parties on its twenty ...
unfccc.intin Annex I to the Convention 10/CP.21 The 2013–2015 review 11/CP.21 Forum and work programme on the impact of the implementation of response measures 12/CP.21 Enhancing climate technology development and transfer through the Technology Mechanism 13/CP.21 Linkages between the Technology Mechanism and the Financial Mechanism of the Convention
Checklist for Type IA and IB PI and Annex A
www.ema.europa.euAnnex A (if applicable) is provided as a separate document in clean PDF format in each EEA language (one document per language) under Mod.1.2. The cover page ‘Annex A’ is removed, the font used is Verdana, size 9, for the text and Arial, size 8, for the page number
ANNEX 1C AGREEMENT ON TRADE-RELATED ASPECTS OF ...
www.wto.organnex 1c agreement on trade-related aspects of intellectual property rights ... part v dispute prevention and settlement part vi transitional arrangements part vii institutional arrangements; final provisions. page 320 agreement on trade-related aspects of intellectual property rights
Annex, Property, Aspects, Trade, Related, Rights, Intellectual, Trade related aspects of intellectual property rights
Medical Certificate
www.ris.bka.gv.atAnlage B Medical Certificate This is to certify that name ..... born ..... in.....
WHO good manufacturing practices for pharmaceutical
www.who.intAnnex 2 WHO good manufacturing practices for pharmaceutical products: main principles1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and essential elements 85 1. Pharmaceutical quality system 85 Quality risk management 88 Product quality review 88 2.
Good, Practices, Pharmaceutical, Annex, Manufacturing, Good manufacturing practices for pharmaceutical